News Related to Hoffmann-La Roche

Related coverage linked through entity extraction aliases.

HER2-Positive Gastric Cancer Pipeline Expands with 20+ Therapies in Development

Mar 22, 2026

Over 20 pharmaceutical companies are developing therapies for HER2-positive gastric cancer, with multiple Phase III trials launched in March 2026 testing novel combination treatments for advanced disease.

Neuromyelitis Optica Spectrum Disorder Pipeline Shows 10+ Active Therapies in Development

Mar 05, 2026

Over 10 companies are developing 12+ pipeline therapies for Neuromyelitis Optica Spectrum Disorder, including Roche's satralizumab Phase III pediatric trial and multiple anti-CD20 monoclonal antibody candidates.